- Research works
- 72 ▲ 68% vs 2018-21
- Citations
- 672 9.4 per fractional work
- Top-10% rate
- 8.5% all institutions 10.0%
- Open access
- 39% world 40%
- International
- 8% world 18%
Not ranked overall: Jiangsu Nhwa Pharmaceutical (China) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.
Which fields of science does Jiangsu Nhwa Pharmaceutical (China) work in?
In 2022-now, 38% of research at Jiangsu Nhwa Pharmaceutical (China) is in Life Sciences, 32% in Health Sciences. Its largest fields are Medicine (27%), Biochemistry, Genetics and Molecular Biology (19%), Engineering (12%). It does 2.0× the world's share of Life Sciences.
Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.
Its 4 domains and 19 fields, with their numbers
- Life Sciences1138.0%
- Health Sciences931.6%
- Medicine827.0%
- Health Professions13.4%
- Veterinary01.0%
- Nursing00.3%
- Physical Sciences829.8%
- Engineering311.6%
- Chemistry26.3%
- Computer Science14.5%
- Materials Science14.0%
- Energy01.2%
- Physics and Astronomy01.2%
- Environmental Science00.8%
- Earth and Planetary Sciences00.4%
- Social Sciences00.6%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 9.6×. Every wedge is a field page.
All 19 fields, with their numbers
- Pharmacology, Toxicology and Pharmaceutics9.58×1 works
- Veterinary7.22×0 works
- Neuroscience6.27×3 works
- Immunology and Microbiology4.36×1 works
- Chemistry4.03×2 works
- Biochemistry, Genetics and Molecular Biology3.51×5 works
- Medicine1.40×8 works
- Energy1.28×0 works
- Health Professions1.28×1 works
- Materials Science1.14×1 works
- Engineering0.77×3 works
- Nursing0.60×0 works
- Computer Science0.57×1 works
- Physics and Astronomy0.53×0 works
- Agricultural and Biological Sciences0.27×0 works
- Earth and Planetary Sciences0.25×0 works
- Environmental Science0.16×0 works
- Economics, Econometrics and Finance0.11×0 works
- Social Sciences0.03×0 works
- Pharmacology, Toxicology and Pharmaceutics 9.6×
- Veterinary 7.2×
- Neuroscience 6.3×
- Immunology and Microbiology 4.4×
- Chemistry 4.0×
- Biochemistry, Genetics and Molecular Biology 3.5×
- Medicine 1.4×
- Energy 1.3×
- Health Professions 1.3×
- Materials Science 1.1×
- Engineering 0.8×
- Nursing 0.6×
- Computer Science 0.6×
- Physics and Astronomy 0.5×
- Agricultural and Biological Sciences 0.3×
- Earth and Planetary Sciences 0.2×
- Environmental Science 0.2×
- Economics, Econometrics and Finance 0.1×
- Social Sciences 0.0×
Who are the top researchers at Jiangsu Nhwa Pharmaceutical (China)?
Ranked on the quality score, Xiangqing Xu and Yinli Qiu lead among researchers whose main affiliation is Jiangsu Nhwa Pharmaceutical (China).
- 1
Xiangqing Xu
China · #2,893,675 worldwide 891 citations · 55 works
- 2
Yinli Qiu
China · #4,043,134 worldwide 406 citations · 18 works
Which keywords describe research at Jiangsu Nhwa Pharmaceutical (China)?
By fractional works in 2022-now, weighted toward what it does more of than the world: Depression, Synaptic Plasticity, Oxidative Stress, Pharmacokinetics, Drug Discovery, Cognitive Impairment, Image Processing and Pharmacology.
- Stress
- Cancer Therapy
- Antiretroviral Therapy
- NMDA Receptor
- Cognitive Impairment
- Pharmacokinetics
- Machine Learning
- Oxidative Stress
- Depression
- Inflammation
- Synaptic Plasticity
- Drug Discovery
- Image Processing
- Pharmacology
- Cancer
- Schizophrenia
Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 16 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 16 words, with their numbers
- Depression3▲ 11×6 topics
- Oxidative Stress2▲ 4.2×11 topics
- Inflammation2▲ 2.8×12 topics
- Machine Learning2▲ 1.65×5 topics
- Synaptic Plasticity2▲ 27×4 topics
- Pharmacokinetics1▲ 19×6 topics
- Drug Discovery1▲ 21×3 topics
- Cognitive Impairment1▲ 16×2 topics
- Image Processing1▲ 8.7×4 topics
- NMDA Receptor1▲ 94×2 topics
- Pharmacology1▲ 15×3 topics
- Antiretroviral Therapy1▲ 22×5 topics
- Cancer1▲ 2.7×7 topics
- Cancer Therapy1▲ 6.3×5 topics
- Schizophrenia1▲ 33×3 topics
- Stress1▲ 9.9×2 topics
Which research topics does Jiangsu Nhwa Pharmaceutical (China) publish most on?
By volume in 2022-now: Treatment of Major Depression, Receptor Mechanisms and Signaling, Tryptophan and brain disorders and Pharmacological Receptor Mechanisms and Effects.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Treatment of Major Depression Pharmacology 1 works
- 2 Receptor Mechanisms and Signaling Molecular Biology 1 works
- 3 Tryptophan and brain disorders Biological Psychiatry 1 works
- 4 Pharmacological Receptor Mechanisms and Effects Molecular Biology 1 works
- 5 Neurotransmitter Receptor Influence on Behavior Cellular and Molecular Neuroscience 1 works
- 6 Acupuncture Treatment Research Studies Complementary and alternative medicine 0 works
- 7 Computational Drug Discovery Methods Computational Theory and Mathematics 0 works
- 8 Nanoplatforms for cancer theranostics Biomedical Engineering 0 works
- 9 Multicomponent Synthesis of Heterocycles Organic Chemistry 0 works
- 10 HIV/AIDS drug development and treatment Infectious Diseases 0 works
How open and international is its research?
Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 40% of research is openly available.
World: 18% is written across borders.
How has Jiangsu Nhwa Pharmaceutical (China)'s research output changed?
Output in 2022-2025 was 68% higher than in 2018-2021.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Jiangsu Nhwa Pharmaceutical (China) as a percentage of every work published that year, 0.00013% in 2024.
Fractional works of Jiangsu Nhwa Pharmaceutical (China) over all fractional works that year. How the balance of science has shifted.
Other research institutions in Xuzhou
- Xuzhou Medical College
- Jiangsu Normal University
- Affiliated Hospital of Xuzhou Medical College
- Xuzhou Children Hospital
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.
Discussion
Ask a question or share a note about Jiangsu Nhwa Pharmaceutical (China). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.